Manus, a bioalternatives scale-up platform, has expanded its partnership with the U.S. Department of Health and Human Services’ (HHS) Center for Industrial Base Management and Supply Chain (IBMSC), which is part of the Administration for Strategic Preparedness and Response (ASPR). Building on a previous $32.4 million award, this expansion adds another $15 million to enable domestic production of shikimic acid, a key starting material for oseltamivir, the active ingredient in Tamiflu. This ini...